Tag: FDA
To Make Drugs More Affordable, President Trump Should Focus on Price Competition

President Trump has tried seemingly everything to lower prescription drug prices. In 2018 alone, he established an international pricing index to prevent overcharging from foreign drug producers, targeted drug rebates between producers and middlemen, and granted Medicare Part D plans more authority to negotiate drug prices. Despite these and other efforts, the prices for thousands of…
Read More »

Keep Government Out of Developing a COVID-19 Vaccine

In late March, California became the first state to issue mandatory “shelter in place” orders. By mid-April, nearly 94 percent of the U.S. population was under order to stay at home. Nearly three months later, millions are still desperate to get back to their lives. Protest rallies held to “reopen the economy” have emerged…
Read More »

More Executive Orders Will Not Fix Healthcare

Draconian measures to “flatten the curve” were implemented to prevent the healthcare sector from becoming overwhelmed with infected patients. Now, as many states reopen for business, it seems relatively few healthcare facilities are overwhelmed. However, much of the healthcare industry is still struggling. Becker Hospital Review finds that more than 250 hospitals are furloughing…
Read More »

Cut Regulations and Get COVID-19 Drugs to Patients

As the coronavirus pandemic continues to ravage the U.S. healthcare system, many healthcare professionals are struggling to find enough medical supplies to treat patients and to avoid becoming infected themselves. A recent New York Post article finds nurses working in a New York City hospital resorted to covering themselves with garbage bags because the…
Read More »

Right-to-Try Laws Can Help Drugmakers Combat the Coronavirus

President Trump recently announced he is extending social distancing guidelines to April 30th. He initially hoped to lift them by Easter. This is far from the first time he has changed his mind on how to best handle the coronavirus pandemic. Although frustrating, the President’s indecisiveness is understandable. The United States recently surpassed China…
Read More »

The Mask Madness of Big Government

As Newsweek reports, people are sewing their own face masks to protect themselves against the coronavirus. Readers might wonder why something as simple as a face mask might be in short supply. As it turns out, such masks are strictly regulated. The federal Food and Drug Administration (FDA) and Centers for Disease Control and…
Read More »

Coronacrisis and Leviathan

In his magisterial Crisis and Leviathan, Robert Higgs shows that the growth of government in the twentieth century can largely be explained by patterns of crisis and response. These crises can be real (World Wars I and II, the Great Depression, stagflation) or imagined (inequality, the various isms). In either case new government programs, agencies, and policies…
Read More »

Favor Local Action to Combat the Coronavirus

Three months ago, the novel coronavirus first appeared in Wuhan, China. Now, it is considered a global pandemic. As of March 18th, the virus has infected over 169,000 individuals, resulting in 8,732 deaths—and counting. The United States as of this writing has approximately 7,769 confirmed cases of the coronavirus and at least 125 related…
Read More »

FDA Acknowledges Coronavirus Is Causing More Drug Shortages

The first outbreak of the coronavirus occurred in China nearly two months ago. The disease quickly spread through the country. As of March 5th, the coronavirus is responsible for over 80,000 confirmed cases and nearly 3,400 deaths across China. Globally over 98,000 people are infected, resulting in nearly 4,000 deaths. At this time, the…
Read More »

FDA’s Approval of Generic Daraprim Offers Lessons on Drugs Prices

In 2015, Turning Pharmaceuticals CEO Martin Shkreli increased the price of the drug Daraprim nearly 5,000 percent from $13.50 to $750 per pill. The price hike generated widespread outrage, earning Shkreli the moniker “Pharma Boy” and the designation, “pharmaceutical greed villain.” Daraprim became “the poster child for the issue of high drug prices.”

  • Catalyst
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org